Tetraphase Pharmaceu
(TTPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -12,035 | -8,957 | -4,689 | -21,560 |
| Depreciation Amortization | 387 | 273 | 138 | 590 |
| Accounts receivable | -2,644 | -844 | -323 | N/A |
| Accounts payable and accrued liabilities | -209 | 204 | 163 | N/A |
| Other Working Capital | -2,982 | -2,106 | -1,088 | 790 |
| Other Operating Activity | 3,291 | 967 | 229 | 310 |
| Operating Cash Flow | $-14,192 | $-10,463 | $-5,570 | $-19,870 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -20 | -10 | -2 | -60 |
| Investing Cash Flow | $-20 | $-10 | $-2 | $-60 |
| Cash Flows From Financing Activities | ||||
| Debt Repayment | -1,517 | -857 | -212 | N/A |
| Common Stock Issued | 23 | 20 | 5 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 7,810 |
| Financing Cash Flow | $-1,494 | $-837 | $-207 | $7,810 |
| Beginning Cash Position | 22,454 | 22,454 | 22,454 | 34,580 |
| End Cash Position | 6,748 | 11,144 | 16,675 | 22,450 |
| Net Cash Flow | $-15,706 | $-11,310 | $-5,779 | $-12,130 |
| Free Cash Flow | ||||
| Operating Cash Flow | -14,192 | -10,463 | -5,570 | -19,870 |
| Capital Expenditure | -20 | -10 | -2 | N/A |
| Free Cash Flow | -14,212 | -10,473 | -5,572 | -19,870 |